Identification of the binding modes of N-phenylphthalimides inhibiting bacterial thymidylate synthase through X-ray crystallography screening

作者: Stefano Mangani , Laura Cancian , Rosalida Leone , Cecilia Pozzi , Sandra Lazzari

DOI: 10.1021/JM2005018

关键词: Plasma protein bindingPeptide sequenceLactobacillus caseiSequence alignmentTransferaseStructure–activity relationshipStereochemistryThymidylate synthaseEnzymeChemistryBiochemistry

摘要: To identify specific bacterial thymidylate synthase (TS) inhibitors, we exploited phenolphthalein (PTH), which inhibits both and human enzymes. The X-ray crystal structure of Lactobacillus casei TS (LcTS) that binds PTH showed multiple binding modes the inhibitor, prevented a classical structure-based drug design approach. overcome this issue, synthesized two phthalimidic libraries were tested against enzymes then performed crystallographic screening active compounds. Compounds 6A, 8A, 12A 40-fold higher affinity for than TS. characterized mode six inhibitors in complexes with LcTS. Of these, 20A, 23A, 24A common unique mode, whereas 8A different, mode. A comparative analysis LcTS obtained pathogenic enabled selection compounds 23A as starting points to be inhibition pathogen

参考文章(26)
G F Maley, F Maley, Properties of a defined mutant of Escherichia coli thymidylate synthase. Journal of Biological Chemistry. ,vol. 263, pp. 7620- 7627 ,(1988) , 10.1016/S0021-9258(18)68543-6
Anastassis Perrakis, Richard Morris, Victor S. Lamzin, Automated protein model building combined with iterative structure refinement. Nature Structural & Molecular Biology. ,vol. 6, pp. 458- 463 ,(1999) , 10.1038/8263
L. Hardy, J. Finer-Moore, W. Montfort, M. Jones, D. Santi, R. Stroud, Atomic structure of thymidylate synthase: target for rational drug design Science. ,vol. 235, pp. 448- 455 ,(1987) , 10.1126/SCIENCE.3099389
Edward Chu, Marc A. Callender, Michael P. Farrell, John C. Schmitz, Thymidylate synthase inhibitors as anticancer agents: from bench to bedside. Cancer Chemotherapy and Pharmacology. ,vol. 52, pp. 80- 89 ,(2003) , 10.1007/S00280-003-0625-9
Stefania Ferrari, Valeria Losasso, Maria Paola Costi, Sequence‐Based Identification of Specific Drug Target Regions in the Thymidylate Synthase Enzyme Family ChemMedChem. ,vol. 3, pp. 392- 401 ,(2008) , 10.1002/CMDC.200700215
Alfonso L. Pogolotti, Peter V. Danenberg, Daniel V. Santi, Kinetics and mechanism of interaction of 10-propargyl-5,8-dideazafolate with thymidylate synthase. Journal of Medicinal Chemistry. ,vol. 29, pp. 478- 482 ,(1986) , 10.1021/JM00154A009
B. Shoichet, R. Stroud, D. Santi, I. Kuntz, K. Perry, Structure-based discovery of inhibitors of thymidylate synthase Science. ,vol. 259, pp. 1445- 1450 ,(1993) , 10.1126/SCIENCE.8451640
Collaborative Computational Project, Number 4, The CCP4 suite: programs for protein crystallography Acta Crystallographica Section D-biological Crystallography. ,vol. 50, pp. 760- 763 ,(1994) , 10.1107/S0907444994003112
Thomas J Stout, Donatella Tondi, Marcella Rinaldi, Daniela Barlocco, Piergiorgio Pecorari, Daniel V Santi, Irwin D Kuntz, Robert M Stroud, Brian K Shoichet, M Paola Costi, None, Structure-based design of inhibitors specific for bacterial thymidylate synthase. Biochemistry. ,vol. 38, pp. 1607- 1617 ,(1999) , 10.1021/BI9815896
Stefania Ferrari, Paola M Costi, Rebecca C Wade, None, Inhibitor Specificity via Protein Dynamics: Insights from the Design of Antibacterial Agents Targeted Against Thymidylate Synthase Chemistry & Biology. ,vol. 10, pp. 1183- 1193 ,(2003) , 10.1016/J.CHEMBIOL.2003.11.012